19-55014228-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000310373.7(GP6):​c.1717A>G​(p.Arg573Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.795 in 833,636 control chromosomes in the GnomAD database, including 266,774 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar.

Frequency

Genomes: 𝑓 0.74 ( 43469 hom., cov: 31)
Exomes 𝑓: 0.81 ( 223305 hom. )

Consequence

GP6
ENST00000310373.7 missense

Scores

15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.833

Publications

21 publications found
Variant links:
Genes affected
GP6 (HGNC:14388): (glycoprotein VI platelet) This gene encodes a platelet membrane glycoprotein of the immunoglobulin superfamily. The encoded protein is a receptor for collagen and plays a critical role in collagen-induced platelet aggregation and thrombus formation. The encoded protein forms a complex with the Fc receptor gamma-chain that initiates the platelet activation signaling cascade upon collagen binding. Mutations in this gene are a cause of platelet-type bleeding disorder-11 (BDPLT11). Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
GP6-AS1 (HGNC:55305): (GP6 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.8510706E-7).
BP6
Variant 19-55014228-T-C is Benign according to our data. Variant chr19-55014228-T-C is described in ClinVar as Benign. ClinVar VariationId is 257413.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.826 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GP6NM_016363.5 linkc.*693A>G 3_prime_UTR_variant Exon 8 of 8 ENST00000417454.5 NP_057447.5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GP6ENST00000417454.5 linkc.*693A>G 3_prime_UTR_variant Exon 8 of 8 1 NM_016363.5 ENSP00000394922.1

Frequencies

GnomAD3 genomes
AF:
0.744
AC:
113073
AN:
151886
Hom.:
43463
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.533
Gnomad AMI
AF:
0.771
Gnomad AMR
AF:
0.799
Gnomad ASJ
AF:
0.791
Gnomad EAS
AF:
0.819
Gnomad SAS
AF:
0.721
Gnomad FIN
AF:
0.876
Gnomad MID
AF:
0.841
Gnomad NFE
AF:
0.832
Gnomad OTH
AF:
0.785
GnomAD2 exomes
AF:
0.794
AC:
157047
AN:
197690
AF XY:
0.794
show subpopulations
Gnomad AFR exome
AF:
0.520
Gnomad AMR exome
AF:
0.830
Gnomad ASJ exome
AF:
0.795
Gnomad EAS exome
AF:
0.832
Gnomad FIN exome
AF:
0.869
Gnomad NFE exome
AF:
0.824
Gnomad OTH exome
AF:
0.810
GnomAD4 exome
AF:
0.807
AC:
549800
AN:
681632
Hom.:
223305
Cov.:
8
AF XY:
0.805
AC XY:
294962
AN XY:
366394
show subpopulations
African (AFR)
AF:
0.526
AC:
10064
AN:
19132
American (AMR)
AF:
0.824
AC:
32684
AN:
39648
Ashkenazi Jewish (ASJ)
AF:
0.795
AC:
16731
AN:
21046
East Asian (EAS)
AF:
0.798
AC:
28532
AN:
35756
South Asian (SAS)
AF:
0.732
AC:
50175
AN:
68564
European-Finnish (FIN)
AF:
0.871
AC:
33068
AN:
37962
Middle Eastern (MID)
AF:
0.784
AC:
3280
AN:
4182
European-Non Finnish (NFE)
AF:
0.827
AC:
347259
AN:
420142
Other (OTH)
AF:
0.796
AC:
28007
AN:
35200
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
6197
12394
18591
24788
30985
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3248
6496
9744
12992
16240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.744
AC:
113122
AN:
152004
Hom.:
43469
Cov.:
31
AF XY:
0.748
AC XY:
55570
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.533
AC:
22048
AN:
41382
American (AMR)
AF:
0.799
AC:
12209
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.791
AC:
2748
AN:
3472
East Asian (EAS)
AF:
0.818
AC:
4223
AN:
5162
South Asian (SAS)
AF:
0.721
AC:
3477
AN:
4820
European-Finnish (FIN)
AF:
0.876
AC:
9274
AN:
10592
Middle Eastern (MID)
AF:
0.839
AC:
245
AN:
292
European-Non Finnish (NFE)
AF:
0.832
AC:
56548
AN:
67996
Other (OTH)
AF:
0.783
AC:
1648
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1315
2630
3946
5261
6576
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
842
1684
2526
3368
4210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.771
Hom.:
16321
Bravo
AF:
0.730
TwinsUK
AF:
0.821
AC:
3043
ALSPAC
AF:
0.817
AC:
3149
ESP6500AA
AF:
0.531
AC:
2026
ESP6500EA
AF:
0.829
AC:
6725
ExAC
AF:
0.769
AC:
90576
Asia WGS
AF:
0.746
AC:
2595
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Platelet-type bleeding disorder 11 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.80
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
8.3
DANN
Benign
0.87
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.0088
N
MetaRNN
Benign
8.9e-7
T
MetaSVM
Benign
-0.93
T
PhyloP100
-0.83
PrimateAI
Benign
0.44
T
PROVEAN
Benign
0.10
N
REVEL
Benign
0.060
Sift
Benign
1.0
T
Sift4G
Benign
0.46
T
Polyphen
0.60
P
Vest4
0.068
MPC
0.33
ClinPred
0.0029
T
GERP RS
-0.47
gMVP
0.022
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1654412; hg19: chr19-55525596; COSMIC: COSV59976643; COSMIC: COSV59976643; API